GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Veterans VET

Education related to antivirals and oncology products.

Contacted: White House Office; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); State, Dept of (DOS); U.S. Trade Representative (USTR); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Office of Management & Budget (OMB)

Immigration IMM

Travel waiver issues related to travel bans due to COVID-19.

Contacted: Office of Management & Budget (OMB); Natl Economic Council (NEC); Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); Office of the Vice President of the United States; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); White House Office; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and value-based purchasing arrangements. H.R.3 - Lower Drug Costs Now Act of 2019 H.R.19 - Lower Costs, More Cures Act of 2019 H.R.259 - Medicaid Extenders Act of 2019 H.R. 7647 - To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage S.2543 - The Prescription Drug Pricing Reduction Act of 2019 S.3129 - Lower Costs, More Cures Act of 2019

Contacted: Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Natl Economic Council (NEC); SENATE; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); State, Dept of (DOS); Office of Management & Budget (OMB)

Bills named: H.R. 259 (116th), S. 2543 (116th), H.R. 3 (116th), S. 3129 (116th), H.R. 19 (116th), H.R. 7647 (116th)

Budget/Appropriations BUD

Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. H.R. 4378 - Continuing Appropriations Act and Health Extenders Act H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act H.R. 8337 - Continuing Appropriations Act of 2021

Contacted: U.S. Trade Representative (USTR); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); State, Dept of (DOS)

Bills named: H.R. 8337 (116th), H.R. 3055 (116th), H.R. 4378 (116th), H.R. 1865 (116th)

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Office of the Vice President of the United States; SENATE; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); White House Office; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries. Administration's Buy American initiatives.

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); White House Office; Natl Economic Council (NEC); U.S. Trade Representative (USTR); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Health Issues HCR

Expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. Highlighting Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatment for COVID-19 (2019 Novel Coronavirus), including: clinical trials, expanded access, compassionate use program, emergency use authorization, donation, distribution and allocation, and reimbursement of Veklury (remdesivir). H.R.6201 - Families First Coronavirus Response Act H.R.748 / S.3548 - CARES Act H.R.3 - Lower Drug Costs Now Act of 2019 H.R.6800 - The Heroes Act H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S.2543 - Prescription Drug Pricing Reduction Act of 2019 S.3013 - Encouraging Innovate Benefit Design to Lower Costs for Seniors Act

Contacted: State, Dept of (DOS); White House Office; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Economic Council (NEC); SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 6074 (116th), H.R. 3 (116th), S. 3013 (116th), H.R. 6800 (116th), S. 3548 (116th), H.R. 748 (116th), H.R. 6201 (116th), S. 2543 (116th)